Japan Tissue Engineering Co

Japan Tissue Engineering Co Employees

The The number of employees of Japan Tissue Engineering Co (7774.T) as of Nov 13, 2026 is 215. In the previous year, The number of employees was 215.00 — a change of 0.00% (lower).

Employees

215

YoY

0.00%

Last updated:

In 2026, Japan Tissue Engineering Co employed 215 people, a 0.00% change from the 215.00 number of employees in the previous year.

The Japan Tissue Engineering Co Employees history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Employees
Date
Employees
Jan 1, 2019
215.00 JPY
Jan 1, 2020
215.00 JPY
Jan 1, 2021
215.00 JPY
Jan 1, 2022
215.00 JPY
Jan 1, 2023
215.00 JPY
Jan 1, 2024
215.00 JPY
Jan 1, 2025
215.00 JPY
Jan 1, 2026
215.00 JPY
The Japan Tissue Engineering Co Employees history
YEAREmployeesYoY
2150.00%
2150.00%
2150.00%
2150.00%
2150.00%
2150.00%
2150.00%
2150.00%
2150.00%
2150.00%
2150.00%
2150.00%
215—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Japan Tissue Engineering Co Stock analysis

What does Japan Tissue Engineering Co do? Japan Tissue Engineering Co., Ltd. generates revenue through three business segments. The Regenerative Medicine Product segment sells autologous cultured epidermis JACE and autologous cultured cartilage JACK to medical institutions. The Regenerative Medicine Outsourcing segment offers CDMO, CRO, consulting, and contract manufacturing services for cell processed products. The Research and Development Support segment sells human cultured tissues developed using the company's advanced culture technology. Medical institutions purchase regenerative medicine products, while pharmaceutical and biotech companies utilize outsourcing services for cell-based therapies. The company's products are sold to healthcare providers and research-focused clients across Japan and potentially internationally. The Regenerative Medicine Product segment focuses on selling JACE and JACK, which are used in medical treatments requiring tissue regeneration. These products are specifically designed for autologous use, meaning they are derived from the patient's own cells. The Outsourcing segment provides specialized services to support the development and manufacturing of cell-based therapies, targeting pharmaceutical and biotech firms. The Research and Development Support segment supplies tissues for research applications, leveraging the company's internal technology to meet client needs in scientific development. JACE and JACK are key products in the Regenerative Medicine Product segment, directly sold to medical institutions for clinical use. The Outsourcing segment serves as a service provider for cell therapy development, offering CDMO and CRO capabilities. The Research and Development Support segment's human cultured tissues are marketed to research organizations seeking advanced cell culture solutions. All segments contribute to the company's revenue by addressing specific needs in regenerative medicine and cell therapy development. Japan Tissue Engineering Co is one of the most popular companies on Eulerpool.

Employees Details

Examining Japan Tissue Engineering Co's Employee Base

Japan Tissue Engineering Co's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Japan Tissue Engineering Co's operational capacity and future potential.

Year-to-Year Comparison

Assessing Japan Tissue Engineering Co's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Japan Tissue Engineering Co's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Japan Tissue Engineering Co’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Japan Tissue Engineering Co stock

The number of employees of Japan Tissue Engineering Co is 215 in 2026.

The number of employees of Japan Tissue Engineering Co changed from 215.00 to 215, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The number of employees Japan Tissue Engineering Co since 2006 – with annual values, charts, and detailed analysis.

The number of employees describes the number of people directly employed by the company.

The number of employees's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The number of employees's Japan Tissue Engineering Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — Japan Tissue Engineering Co

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Japan Tissue Engineering Co